Evidence map›Paper›PMID 33301425›Full record

ArticleThe Journal of clinical investigation2021

Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo.

Francesco R Simonetti, Hao Zhang, Garshasb P Soroosh, Jiayi Duan, Kyle Rhodehouse, Alison L Hill, Subul A Beg, Kevin McCormick, Hayley E Raymond, Christopher L Nobles and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 172 citations in OpenAlex.

  1. Article
  2. Article
  3. HCV-specific CD4EBioMedicine · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Francesco R SimonettiDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hao ZhangDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Garshasb P SorooshDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jiayi DuanDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kyle RhodehouseDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alison L HillInstitute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Subul A BegDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kevin McCormickDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Hayley E RaymondDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Christopher L NoblesDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
John K EverettDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Kyungyoon J KwonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jennifer A WhiteDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jun LaiDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Joseph B MargolickDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Rebecca HohDivision of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, California, USA.
Steven G DeeksDivision of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, California, USA.
Frederic D BushmanDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Janet D SilicianoDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Robert F SilicianoDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins University · USUniversity of Pennsylvania · USGlobal Solutions for Infectious Diseases · USHoward Hughes Medical Institute · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
First-in-human study of two anti-SARS CoV-2 antibodies in health volunteersUM1AI126620 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J, RILEY, JAMES L. · 2016 to 2021
$24.5M
Sequencing and Viral Evolution CoreU19AI117950 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WHERRY, E. JOHN · 2015 to 2019
$12.0M
Linking insertional mutagenesis and cell function to improve CAR T cell therapyR01CA241762 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BUSHMAN, FREDERIC D, MELENHORST, JAN J · 2019 to 2023
$3.1M
Optimization HIV Inhibition by Allosteric Integrase InhibitorsR01AI129661 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BUSHMAN, FREDERIC D, VAN DUYNE, GREGORY D · 2017 to 2021
$2.2M
Quantification and prediction of treatment efficacy for HIV cure strategiesDP5OD019851 · OD · JOHNS HOPKINS UNIVERSITY · PI HILL, ALISON LYNN · 2014 to 2018
$2.1M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA241762NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI045008NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI129661NIAID NIH HHS U19 AI117950NIAID NIH HHS UM1 AI126620NIH HHS DP5 OD019851
6 · The paper itself

Abstract

Clonal expansion of infected CD4+ T cells is a major mechanism of HIV-1 persistence and a barrier to achieving a cure. Potential causes are homeostatic proliferation, effects of HIV-1 integration, and interaction with antigens. Here, we show that it is possible to link antigen responsiveness, the full proviral sequence, the integration site, and the T cell receptor β-chain (TCRβ) sequence to examine the role of recurrent antigenic exposure in maintaining the HIV-1 reservoir. We isolated CMV- and Gag-responding CD4+ T cells from 10 treated individuals. Proviral populations in CMV-responding cells were dominated by large clones, including clones harboring replication-competent proviruses. TCRβ repertoires showed high clonality driven by converging adaptive responses. Although some proviruses were in genes linked to HIV-1 persistence (BACH2, STAT5B, MKL1), the proliferation of infected cells under antigenic stimulation occurred regardless of the site of integration. Paired TCRβ and integration site analysis showed that infection could occur early or late in the course of a clone's response to antigen and could generate infected cell populations too large to be explained solely by homeostatic proliferation. Together, these findings implicate antigen-driven clonal selection as a major factor in HIV-1 persistence, a finding that will be a difficult challenge to eradication efforts.

Indexed as

Clonal Selection, Antigen-MediatedAdultCD4-Positive T-LymphocytesFemalegag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHumansMaleVirus IntegrationVirus Latencygag Gene Products, Human Immunodeficiency VirusAdaptive immunityAIDS/HIVClonal selectionImmunologyT cells

Identifiers

PMID33301425
PMCPMC7843227
OpenAlexW3111997123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.